Source: Annual Congress 2003 - Pulmonary injury and repair: from cell studies to clinical solutions
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. A. Kolodkina, T. P. Ses, L. N. Novikova, A. S. Kalinina, G. P. Orlova (St Petersburg, Russia). Role of neutrophil mechanisms of inflammation in pathogenesis of different types of pulmonary fibrosis. Eur Respir J 2003; 22: Suppl. 45, 2913

Member's Comments

No comment yet.

Related content which might interest you: Pathogenesis of idiopathic pulmonary fibrosis: role of neutrophil inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 102s Year: 2006 The role of monocyte inflammation and oxidant stress in the etiopathogenesis of cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008 The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008 The role of viruses in the pathogenesis of pulmonary fibrosis Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease Year: 2021 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease. Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Cellular interactions in the pathogenesis of interstitial lung diseases Source: Eur Respir Rev 2015; 24: 102-114 Year: 2015 Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 The role of oxidative damage in pathogenesis of experimental pulmonary emphysema Source: Annual Congress 2007 - Unravelling molecular mysteries of COPD Year: 2007 The pathogenesis of pulmonary fibrosis: a moving target Source: Eur Respir J 2013; 41: 1207-1218 Year: 2013 Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 FIZZ1: a new pathway in silica-induced inflammatory mediators and pulmonary fibrosis Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation Year: 2018 Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy Source: Eur Respir Rev, 31 (163) 210241; 10.1183/16000617.0241-2021 Year: 2022 The role of systemic markers of inflammation in bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Investigation of the citrullination pathway in the pathogenesis of fibrotic lung disorders Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007